NASDAQ: CRME TSX: COM
VANCOUVER, Sept. 16, 2013 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME /
TSX: COM) today announced completion of the transfer of
commercialization responsibility for BRINAVESS™ (vernakalant IV) in the
European Union (EU) from its former......
More...
